Form 4: Precigen Director James S. Turley Reports Changes in Beneficial Ownership

Director James S. Turley reports acquisition and disposal of Precigen, Inc. common stock and restricted stock units.

Summary

• On March 13, 2025, Director James S. Turley acquired 35,919 shares of Precigen common stock at $1.74 per share in lieu of an annual retainer.
• On the same day, he was granted 71,839 restricted stock units (RSUs) that vest in full on March 13, 2026.
• Also on March 13, 2025, Turley acquired an option to purchase 83,517 shares of common stock at $1.74, exercisable from March 13, 2025, to March 13, 2035.
• On March 14, 2025, 87,412 RSUs vested in full.
• Following these transactions, Turley directly owns 595,772 shares of Precigen common stock and no longer owns the 87,412 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing transactions by a company director. The acquisition of shares could be seen as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of shares and RSUs by a director could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency to the market regarding their transactions in the company's securities.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how they interpret the director's actions.

Key Dates